These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27055653)

  • 21. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data.
    Fotheringham J; Jacques RM; Fogarty D; Tomson CR; El Nahas M; Campbell MJ
    Nephrol Dial Transplant; 2014 Feb; 29(2):422-30. PubMed ID: 24052459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of comorbidities on survival in patients >80 years of age at onset of renal replacement therapy: data from the ERA-EDTA Registry.
    Helve J; Kramer A; Abad Diez JM; Aresté-Fosalba N; Arici M; Cases A; Collart F; Heaf J; De Meester J; Nordio M; Palsson R; Pobes A; Rydell H; Reisæter AV; Massy ZA; Jager KJ; Finne P
    Nephrol Dial Transplant; 2021 Mar; 36(4):688-694. PubMed ID: 33537775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.
    Visser A; Noordzij M; Gansevoort RT; Van Biesen W; Reijneveld SA; Jager KJ; de Jong PE; Izaks GJ; Dijkstra GJ; De Meester J; Hoitsma AJ; Franssen CF
    Nephrol Dial Transplant; 2012 Feb; 27(2):803-9. PubMed ID: 21669881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry.
    Yamagata K; Nakai S; Iseki K; Tsubakihara Y;
    Ther Apher Dial; 2012 Apr; 16(2):111-20. PubMed ID: 22458388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making.
    Couchoud C; Dantony E; Elsensohn MH; Villar E; Ecochard R;
    Nephrol Dial Transplant; 2013 Sep; 28(9):2372-82. PubMed ID: 23787553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival prognosis after the start of a renal replacement therapy in the Netherlands: a retrospective cohort study.
    Hemke AC; Heemskerk MB; van Diepen M; Weimar W; Dekker FW; Hoitsma AJ
    BMC Nephrol; 2013 Nov; 14():258. PubMed ID: 24256551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.
    Lassalle M; Ayav C; Frimat L; Jacquelinet C; Couchoud C;
    Nephrol Ther; 2015 Apr; 11(2):78-87. PubMed ID: 25457107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
    Caskey F; Webb L; Gilg J; Fogarty D
    Nephron Clin Pract; 2010; 115 Suppl 1():c103-16. PubMed ID: 20413944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy.
    Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M
    Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis.
    Chinnadurai R; Flanagan E; Kalra PA
    J Nephrol; 2019 Dec; 32(6):1003-1009. PubMed ID: 31555974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we improve early mortality in patients receiving renal replacement therapy?
    Metcalfe W; Khan IH; Prescott GJ; Simpson K; MacLeod AM
    Kidney Int; 2000 Jun; 57(6):2539-45. PubMed ID: 10844623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity recording and predictive power of comorbidities in the Australia and New Zealand dialysis and transplant registry compared with administrative data: 2000-2010.
    Kotwal S; Webster AC; Cass A; Gallagher M
    Nephrology (Carlton); 2016 Nov; 21(11):930-937. PubMed ID: 26636746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of patients dying within one year of starting renal replacement therapy.
    Walters G; Warwick G; Walls J
    Am J Nephrol; 2000; 20(5):358-63. PubMed ID: 11092991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy.
    Haapio M; Helve J; Kurimo P; Forslund T; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2012 Mar; 27(3):1157-63. PubMed ID: 21810761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation.
    Dusseux E; Albano L; Fafin C; Hourmant M; Guérin O; Couchoud C; Moranne O
    Kidney Int; 2015 Jul; 88(1):121-9. PubMed ID: 25671769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.